DDB classifies GBL as dangerous drug

September 05, 2019

THE Dangerous Drugs Board has  declared Gamma-Butyrolactone or GBL a dangerous drug and  said those in possession of the known “date rape drug” will be subjected to immediate arrest, Philippine Drug Enforcement Agency chair Director General Aaron N. Aquino announced yesterday.

The PDEA chief said the inclusion of GBL to the list of dangerous drugs was due to the passage by the DDB of Board Regulation No. 4, Series of 2019 with the subject “Inclusion of Gamma-Butyrolactone (GBL), and all Compounds, Mixtures, or Preparations Containing Any Quantity of the Same, by Whatever Official, Common or Usual Names, Chemical Name or Designated Brand Name, in the List of Dangerous Drugs.”

Aquino  said  in the Philippines, GBL is being used as a “date-rape drug” with stronger doses that can cause sleepiness, confusion, and dizziness, making a person vulnerable to sexual assault.

Aquino explained that GBL is a liquid compound used as a solvent and sometimes taken as a recreational drug being metabolized in the body producing an active substance called as “Gamma-Hydroxybutyrate” or GHB, a compound listed in the schedule II of the 1971 convention- the drug category that has high potential for abuse which may lead to severe psychological and physical dependence.

“This is another leap in our pursuit to regulate the manufacture, sale and illicit use of this substance that may lead to addiction,” Aquino said while adding that the new  directive will minimize the importation, exportation manufacture, sale, and use of GBL as other countries like the United States, Australia, Canada, Netherlands, Sweden, United Kingdom, Italy and Hongkong have also regulated this substance.